Use of antiviral drugs to reduce COVID-19 transmission

O Mitjà, B Clotet - The Lancet Global Health, 2020 - thelancet.com
As the coronavirus disease 2019 (COVID-19) spreads, … to achieve outbreak control of
COVID-19 when the basic … acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2…

Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results

WHO Solidarity Trial Consortium - New England journal of …, 2021 - Mass Medical Soc
… We randomly assigned inpatients with Covid-19 equally between one of the trial drug … trial
drug and its control (drug available but patient assigned to the same care without that drug). …

Antiviral drug discovery for the treatment of COVID-19 infections

TI Ng, I Correia, J Seagal, DA DeGoey, MR Schrimpf… - Viruses, 2022 - mdpi.com
… coverage to combat the current COVID-19 crisis as well as emerging coronaviruses with …
the discovery of antiviral drugs for COVID-19, covering the functions of important antiviral targets …

Current strategies of antiviral drug discovery for COVID-19

M Mei, X Tan - Frontiers in Molecular Biosciences, 2021 - frontiersin.org
… by the US FDA for treating COVID-19. However, remdesivir’s … antiviral drugs are still urgently
needed. We will discuss the current status of the drug discovery efforts against COVID-19

Antiviral treatment of COVID-19

S Yavuz, S Ünal - Turkish journal of medical sciences, 2020 - journals.tubitak.gov.tr
… start antiviral treatment as soon as possible also for COVID-19 … Combined usage of antiviral
drugs for COVID-19 patients … case; adverse drug reactions and drug-drug interactions should …

Efficacy of repurposed antiviral drugs: lessons from COVID-19

MA Martinez - Drug Discovery Today, 2022 - Elsevier
… New antiviral drugs targeting different SARS-CoV-2 … drugs on COVID-19. Experience with
previous virus pandemics has shown us that developing an ample repertoire of antiviral drugs

[HTML][HTML] Antivirals for COVID-19: a critical review

A Frediansyah, R Tiwari, K Sharun, K Dhama… - … and global health, 2021 - Elsevier
drug has been approved for the treatment of COVID-19. Rapid assessment of the currently
available antiviral drugs to be used for COVID-19 … well as discovering newer drugs. Since the …

Accelerating antiviral drug discovery: lessons from COVID-19

A von Delft, MD Hall, AD Kwong, LA Purcell… - Nature Reviews Drug …, 2023 - nature.com
… executed rapid drug discovery campaigns and developed novel antivirals amid a fast-…
development efforts in COVID-19. We outline key lessons from rapid antiviral drug discovery efforts…

A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

C Liang, L Tian, Y Liu, N Hui, G Qiao, H Li, Z Shi… - European journal of …, 2020 - Elsevier
… ) for remdesivir to treat COVID-19 patients. In light of the COVID-19 pandemic, this review …
, intellectual properties, anti-coronavirus mechanisms, preclinical research and clinical trials, …

Favipiravir: A new and emerging antiviral option in COVID-19

U Agrawal, R Raju, ZF Udwadia - Medical Journal Armed Forces India, 2020 - Elsevier
… with which the COVID-19 pandemic has spread across the world has only served to expose
how inadequate our available antiviral drug options are. Repurposed antiviral drugs have all …